Express Scripts Appeal Guide: Forms, Fax Numbers, and What Wins in 2026
Exact Express Scripts (ESI) appeal forms, timelines, and the clinical documentation that overturns most pharmacy benefit denials on first appeal.
Understanding Express Scripts
Express Scripts (ESI) is the pharmacy benefit manager for Cigna, many Aetna plans, the TRICARE program, federal employees, and dozens of commercial health plans. When a drug is denied at the pharmacy counter or on an ePA request and the plan uses ESI, the appeal goes through ESI — not the health plan directly.
This matters because the appeal forms, timelines, and policies all come from ESI's Coverage Determination and Prior Authorization team, not the health insurer's medical necessity team. Sending an appeal to the wrong address causes 30-60 day delays.
The Right Forms to Use
Express Scripts uses two primary forms:
- ✓ Prior Authorization Request Form (used for initial PA submission and reconsiderations)
- ✓ Coverage Determination Request / Redetermination Form (used for Medicare Part D plans administered by ESI)
Submission Channels
Fastest: ePA through CoverMyMeds, Surescripts, or direct ESI portal at esrx.com/pa.
Fax: 1-877-251-5896 (commercial) / 1-877-328-9660 (Medicare).
Phone: 1-800-753-2851 (commercial prescriber line).
Mail: Express Scripts, Attn: Prior Authorization Department, PO Box 66587, St. Louis, MO 63166-6587.
Appeal Timelines
Commercial: 180 days to file a first-level appeal after denial. ESI has 30 days to respond (standard), 72 hours (expedited).
Medicare Part D: 60 days to file a redetermination. ESI has 7 calendar days (standard), 72 hours (expedited).
Always request expedited review when the denial would delay necessary therapy.
What to Include in an ESI Appeal
Every successful appeal to Express Scripts contains these elements:
- ✓ Patient identification: name, DOB, ESI member ID, group number
- ✓ Drug, strength, directions, quantity, days supply requested
- ✓ ICD-10 diagnosis code with specificity
- ✓ Prior therapy documentation with dates, doses, duration, and discontinuation reason
- ✓ FDA labeling reference or guideline citation supporting the use
- ✓ Specific rebuttal to the denial reason in the original letter
- ✓ Prescriber attestation with NPI and contact
Common ESI Denial Patterns
ESI denies most often for: step therapy not met, quantity limits exceeded, non-formulary without exception, and "not FDA-approved for diagnosis." Each has a specific winning strategy:
- ✓ Step therapy: document every prior agent with dose/duration/outcome. If none tried, cite the contraindication.
- ✓ Quantity limit: attach FDA dosing labeling for higher doses, or weight-based calculation for pediatric patients.
- ✓ Non-formulary: submit formulary exception with clinical justification for each formulary alternative's failure or contraindication.
- ✓ Off-label: cite AHFS DI, NCCN compendium, or peer-reviewed RCT supporting the indication.
Peer-to-Peer with ESI Medical Directors
ESI peer-to-peer requests are handled by the Clinical Intake team at 1-800-753-2851. P2P conversion rates for specialty drug appeals are approximately 60% when the clinician comes prepared with guideline citations and chart-specific prior therapy documentation. Schedule P2Ps by calling the clinical intake line and requesting a "medical director review."
How RxCheckUp Handles ESI Appeals
RxCheckUp identifies when a claim routes through Express Scripts vs. the health plan directly, generates the appropriate ESI-compliant appeal letter, cites the matching Express Scripts clinical criteria, and routes to the correct submission channel (ePA, fax, or mail). Average time from denial to appeal submission: under 5 minutes.